These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6147832)

  • 1. Beta-adrenergic blockers. Choosing among them.
    Vlietstra RE; McGoon MD
    Postgrad Med; 1984 Sep; 76(3):71-3, 76-7, 80. PubMed ID: 6147832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new beta-adrenergic antagonists.
    Chung DC; Laschuk MJ
    Can Anaesth Soc J; 1984 Jul; 31(4):430-3. PubMed ID: 6146393
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative review of beta-blocking agents.
    Jackson EA; Sullman SA
    Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative pharmacokinetics of beta-blockers].
    Kiechel JR; Meier J
    Nouv Presse Med; 1978 Sep; 7(31):2685-7. PubMed ID: 30943
    [No Abstract]   [Full Text] [Related]  

  • 5. Pindolol: a pharmacokinetic comparison with other beta-adrenoceptor blocking agents.
    Meier J
    Acta Med Scand Suppl; 1977; 606():65-70. PubMed ID: 19931
    [No Abstract]   [Full Text] [Related]  

  • 6. Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
    Ochs HR; Greenblatt DJ; Arendt RM; Schäfer-Korting M; Mutschler E
    Arzneimittelforschung; 1985; 35(10):1580-2. PubMed ID: 2866772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Adrenoceptor antagonists: new drugs and new indications.
    Koch-Weser J; Frishman WH
    N Engl J Med; 1981 Aug; 305(9):500-6. PubMed ID: 6114433
    [No Abstract]   [Full Text] [Related]  

  • 8. A toxicological review of beta-adrenergic blockers.
    Jackson CD; Fishbein L
    Fundam Appl Toxicol; 1986 Apr; 6(3):395-422. PubMed ID: 2870945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular penetration of beta-adrenergic blocking agents. An experimental study with atenolol, metoprolol, timolol and propranolol.
    Ros FE; Innemee HC; van Zwieten PA
    Doc Ophthalmol; 1980 Apr; 48(2):291-301. PubMed ID: 6105048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
    Shulkin BL; Peele ME; Utiger RD
    Endocrinology; 1984 Sep; 115(3):858-61. PubMed ID: 6146516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenolol.
    Lennard MS; Tucker GT; Silas JH; Woods HF
    Xenobiotica; 1986 May; 16(5):435-47. PubMed ID: 2874665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic comparison of pindolol with other beta-adrenoceptor-blocking agents.
    Meier J
    Am Heart J; 1982 Aug; 104(2 Pt 2):364-73. PubMed ID: 6125095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy.
    Kawakami K; Nagatomo T; Abe H; Kikuchi K; Takemasa H; Anson BD; Delisle BP; January CT; Nakashima Y
    Br J Pharmacol; 2006 Mar; 147(6):642-52. PubMed ID: 16314852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
    Gangji D; Juvent M; Niset G; Wathieu M; Degreve M; Bellens R; Poortmans J; Degre S; Fitzsimons TJ; Herchuelz A
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):29S-35S. PubMed ID: 6146337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).
    Vukovich RA; Foley JE; Brown B; Willard DA; Buckley M; O'Kelly D; Fitzgerald D; Tormey W; Darragh A
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):167S-172S. PubMed ID: 37871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta receptor blockaders. Pharmacokinetics and therapeutic effects].
    Bolte HD
    Internist (Berl); 1982 Nov; 23(11):616-23. PubMed ID: 6130051
    [No Abstract]   [Full Text] [Related]  

  • 17. Formation of the N-nitroso derivatives of six beta-adrenergic-blocking agents and their genotoxic effects in rat and human hepatocytes.
    Robbiano L; Martelli A; Allavena A; Mazzei M; Gazzaniga GM; Brambilla G
    Cancer Res; 1991 May; 51(9):2273-9. PubMed ID: 1673086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class III action of beta-blocking agents.
    Taggart P; Donaldson R; Abed J; Nashat F
    Cardiovasc Res; 1984 Nov; 18(11):683-9. PubMed ID: 6149809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blocker brain concentrations in man.
    Cruickshank JM; Neil-Dwyer G
    Eur J Clin Pharmacol; 1985; 28 Suppl():21-3. PubMed ID: 2865144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of hydralazine on the pharmacokinetics of three different beta adrenoceptor antagonists: metoprolol, nadolol, and acebutolol.
    Jack DB; Kendall MJ; Dean S; Laugher SJ; Zaman R; Tenneson ME
    Biopharm Drug Dispos; 1982; 3(1):47-54. PubMed ID: 6123352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.